CLINICAL_TRIALS
research
· 2017-08-25
Clinical Trial Update: Biomarker Study in Pancreatic Neuroendocrine Tumours
Summary
An update on a biomarker study in pancreatic neuroendocrine tumors sponsored by Uppsala University; the current status is not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Uppsala University | Conditions: Neuroendocrine Tumors | Status: UNKNOWN